Changes in the evolution of meningococcal disease, 2001-2008, Catalonia (Spain)

Vaccine

Volumn 27, Issue 25-26, 2009, Pages 3496-3498

  Martínez, Ana I ^a   Dominguez, Angela ^b,c   Oviedo, Manuel ^a,c   Minguell, Sofia ^d   Jansa, Josep M ^a,c   Codina, Gemma ^e   Vazquez, Julio A ^f  

^a Generalitat of Catalonia ^*  (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^d Department of Health   (Spain)

^e HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^f INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Case fatality rate; Epidemiology; Meningococcal disease

Indexed keywords

MENINGOCOCCUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; BACTERIAL STRAIN; BLOOD GROUP TYPING; CHILD; CONJUGATION; CONTROLLED STUDY; FATALITY; HUMAN; INCIDENCE; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEROTYPE; SPAIN; VACCINATION;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MENINGOCOCCAL INFECTIONS; MIDDLE AGED; NEISSERIA MENINGITIDIS; SEROTYPING; SPAIN; TIME FACTORS; VACCINATION;

EID: 67349095058     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.01.045     Document Type: Article

References (12)

1. Granoff D.M., Harrison L.H., and Borrow R. Meningococcal vaccine. In: Plotkin A.S., Orenstein W., and Offit P. (Eds). Vaccines. 5th ed. (2008), Saunders Elsevier, Philadelphia 399-434
2. Domínguez A., Cardeñosa N., Izquierdo C., Sánchez F., Margall N., Vázquez J.A., et al. Prevalence of Neisseria meningitidis carriers in the school population of Catalonia, Spain. Epidemiol Infect 127 (2001) 425-433
3. Stuart J. Public health management. In: Frosch M., and Maiden M.C.J. (Eds). Handbook of meningococcal disease (2006), Wiley-Vch Verlag, Weinheim 519-531
4. Cardeñosa N., Domínguez A., Martínez A., and Salleras L. Epidemiology of serogroup C meningococcal disease in Catalonia (1997-2004). Vacunas 6 (2005) 51-55
5. De Wals P. Meningococcal C vaccines: the Canadian experience. Pediatr Infect Dis J 23 Suppl. 12 (2004) S280-S284
6. Rosenstein N.E., Perkins B.A., Stephens D.S., Lefkowitz L., Cartter M.L., Danila R., et al. The changing epidemiology of meningococcal disease in the United States, 1992-1996. J Infect Dis 180 (1999) 1894-1901
7. Racoosin J.A., Whitney C.G., Conover C.S., and Diaz P.S. Serogroup Y meningococcal disease in Chicago 1991-1997. JAMA 280 (1998) 2094-2098
8. Lingappa J.R., Al-Rabeah A.M., Hajjeh R., Mustafa T., Fatani A., Al-Bassam T., et al. Serogroup W-135 meningococcal disease during the Hajj, 2000. Emerg Infect Dis 9 (2003) 665-671
9. Nathan N., Rose A.M., Legros D., Tiendrebeogo S.R., Bachy C., BjØrlØw E., et al. Meningitis serogroup W135 outbreak, Burkina Faso, 2002. Emerg Infect Dis 13 (2007) 920-923
10. Ceyhan M., Yildirim I., Balmer P., Borrow R., Dikici B., Turgut M., et al. A prospective study of etiology of childhood acute bacterial meningitis, Turkey. Emerg Infect Dis 7 14 (2008) 1089-1096
11. Alcalà B., Arreaza l, Salcedo C., Uría M.J., De la Fuente L., and Vázquez J.A. Capsule switching among C:2b:P1.2.5 meningococcal epidemic strains after mass immunization campaign, Spain. Emerg Infect Dis 8 (2002) 1512-1514
12. Vázquez JA. Situación de la epidemiología de la enfermedad meningocócica. Available at: http://www.seimc.org/control/revi Bacte/pdf7epimening.pdf.